- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RadNet buys nine centers, sells one
FDA clears Ziehm mobile C-arm
RadNet buys nine centers, sells one
No sooner had RadNet completed its two-month-old deal to acquire nine New Jersey imaging centers than the company began whittling down the purchase price, turning new assets into hard cash. RadNet sold off a single-modality open MRI center in southern New Jersey, along with some legacy image management systems, for $650,000, thus retrieving a chunk of the $2.1 million paid to Medical Resources for the nine facilities. Tristate Imaging bought the center, which RadNet described as being outside the market served by the closest RadNet centers. The acquisition price will drop further if RadNet sells, as planned, a building in Union, NJ, that it acquired in the deal. The Medical Resources acquisition is part of a strategy to connect RadNet's Mid-Atlantic and southern New York operations. These complement core operations in California, Maryland, and Delaware. All told, RadNet operates a network of 175 fully owned and operated outpatient imaging centers.
FDA clears Ziehm mobile C-arm
The FDA has cleared the Vision RFD, a mobile C-arm from Ziehm Imaging. The compact system is designed for use in endovascular surgery, interventional cardiology, and interventional radiology. It features a flat-panel sensor as part of its digital imaging chain. A large C-arm opening and 165º orbital rotation allow easy patient access.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
